Vimarsana
Biggest News Aggregation in the World

Page 18 - Catalyst Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Catalyst Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Catalyst Program Today - Breaking & Trending Today

Lawrence City Commission to consider tax breaks for expansion of beverage distribution plant | News, Sports, Jobs - Lawrence Journal-World: news, information, headlines and events in Lawrence, Kansas - Vimarsana News

Lawrence City Commission to consider tax breaks for expansion of beverage distribution plant | News, Sports, Jobs - Lawrence Journal-World: news, information, headlines and events in Lawrence, Kansas

Lawrence City Hall, 6 E. Sixth St., is pictured on May 3, 2016. City leaders will soon consider providing sales and property tax breaks for the expansion of an alcoholic beverage distribution company in northern Lawrence. As part of its meeting Tuesday, the Lawrence City Commission will consider an economic development assistance request from LRICO Services LLC to expand the existing Standard Beverage building located in the Timberedge Industrial Park, according to a city staff memo to the commission. The company is looking for sales tax exemptions on construction materials and labor as wel...

Novus Therapeutics Appoints June Lee, M.D., to Board of Directors - Vimarsana News

Novus Therapeutics Appoints June Lee, M.D., to Board of Directors

Posted on 247 Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those living with immunological diseases, today announced the appointment of June Lee, M.D., to the company’s Board of Directors. “We are delighted to welcome June to our board of directors as Novus continues on this next phase of its evolution,” said David-Alexandre C. Gros, M.D., Chief Exec...